When President Biden appointed Dr. Robert M. Califf as commissioner of the U.S. Food and Drug Administration, it wasn’t his first walk through the turnstile.
He’d already served in the same position in Obama’s final year as president. And, by turnstile, the description fits perfectly: He’s admitted that he has conflicts of interest tied to at least a dozen different pharmaceutical companies.
Not only that, Duke University, where he worked as an adjunct professor of medicine (cardiology) and former director of the Duke Clinical Research Institute, received money from 23 Big Pharma companies while he was there — not to mention “the research operations over which Califf presided resulted in major fraud,” according to Freedom Magazine.
“It would be dangerously naïve to think he has not developed deeply ingrained attitudes that tilt in favor of the medical device and drug industries,” Michael Carome, director of the health research group at Public Citizen, a consumer activist group in Washington, D.C., said.
SOURCE:
Freedom Magazine April 20, 2023